市场调查报告书
商品编码
1370418
细胞激素市场:2023-2028 年全球产业趋势、份额、规模、成长、机会与预测Cytokine Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 |
2022年全球细胞激素市场规模达833亿美元。展望未来,IMARC集团预计到2028年市场规模将达到1,305亿美元,2023-2028年复合年增长率(CAGR)为7.66%。
细胞激素是指特定细胞释放的一组蛋白质、胜肽或糖蛋白,用于控制免疫系统和血球的生长和活性。由于其高亲和力皮摩尔浓度,它可以调节免疫、发炎和造血功能。它通常被注射到皮下或肌肉或静脉中,以帮助预防或控制化疗副作用并治疗癌症。它还透过发送使异常细胞死亡和正常细胞寿命更长的信号来增强抗癌活性。目前,它在细胞和基因治疗、各种细胞类型的扩增和分化、离体培养和其他治疗方法中已被广泛采用。
冠状病毒病 (COVID-19) 透过飞沫传播,飞沫可诱导促炎细胞因子过量产生,导致急性呼吸窘迫症候群 (ARDS) 加重和组织损伤。由于组织损伤可能导致多重器官衰竭和死亡,因此对细胞因子来管理患者、提高存活率并降低死亡率的解决方案的需求不断增加。除此之外,癌症盛行率的不断上升,加上对微创手术(MIS)的需求不断增加,微创手术可以减少术后疼痛和併发症,并加快恢復时间,从而促进了市场的成长。此外,由于细胞因子可作为健康和疾病的诊断、预后和治疗剂以及生物标记物,因此它们在多种功能中越来越受到关注,包括免疫细胞分化、发炎、血管生成、肿瘤发生、神经生物学和病毒发病机转。除此之外,异位性皮肤炎(AD) 是一种复发性、慢性、发炎性皮肤病,伴随严重搔痒,其病例不断增加,正在推动AD 发病机制中对新细胞因子的需求,并开发改进的治疗标靶。
The global cytokine market size reached US$ 83.3 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 130.5 Billion by 2028, exhibiting a growth rate (CAGR) of 7.66% during 2023-2028.
A cytokine refers to a group of proteins, peptides, or glycoproteins released by specific cells to control the growth and activity of the immune system and blood cells. It can regulate immunity, inflammation, and hematopoiesis on account of its high-affinity picomolar concentrations. It is usually injected under the skin or into muscles or veins to help prevent or manage chemotherapy side effects and treat cancer. It also boosts anti-cancer activities by sending signals that make abnormal cells die and normal cells live longer. Presently, it is gaining widespread adoption in cell and gene therapy for the expansion and differentiation of various cell types, ex vivo cultures, and other therapeutic approaches.
The coronavirus disease (COVID-19) is transmitted via droplets that can induce the excessive production of proinflammatory cytokines and lead to acute respiratory distress syndrome (ARDS) aggravation and tissue damage. As tissue damage can result in multi-organ failure and death, there is a rise in the demand for solutions that target cytokines to manage patients, improve survival rates, and reduce mortality. Apart from this, the increasing prevalence of cancer, in confluence with the escalating demand for minimally invasive surgeries (MIS) that provide less post-operative pain and complications and faster recovery time, is contributing to the market growth. Moreover, as cytokines act as diagnostic, prognostic, and therapeutic agents and biomarkers for health and diseases, they are gaining traction in diverse functions, including immune cell differentiation, inflammation, angiogenesis, tumorigenesis, neurobiology, and viral pathogenesis. Besides this, the rising cases of atopic dermatitis (AD), a recurrent, chronic, and inflammatory skin disease that processes with severe itchiness, is driving the demand for new cytokines in the pathogenesis of AD and developing improved therapeutic targets.
IMARC Group provides an analysis of the key trends in each sub-segment of the global cytokine market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on cytokine type, therapeutic application and end user.
Tumor Necrosis Factor-TNF
Interleukins-Il
Interferons-IFN
Epidermal Growth Factor-EGF
Others
Cancer
Asthma and Airway Inflammation
Arthritis
Others
Pharmaceutical and Biotechnology Companies
Contract Research Organizations
Academic and Research Institutes
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
How has the global cytokine market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global cytokine market?
What are the key regional markets?
What is the breakup of the market based on the cytokine type?
What is the breakup of the market based on the therapeutic application?
What is the breakup of the market based on the end user?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global cytokine market and who are the key players?
What is the degree of competition in the industry?